marketcaparena
Search

    ROIV

    Roivant Sciences Ltd.

    Company overview

    Market capitalization
    $26.71B
    Employees
    721
    Latest publication
    2026-09-29
    About Roivant Sciences Ltd.

    Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease; neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising a lipid nanoparticle (LNP) platform and a ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-06-30 · USDQ4 20252026-03-31 · USDQ3 20252025-12-31 · USDQ2 20252025-09-30 · USDQ1 20252025-06-30 · USDQ3 20242024-12-31 · USDQ4 20242024-03-31 · USDQ2 20242023-09-30 · USD
    Total Revenue1,442,000USD2,520,000USD1,999,000USD1,571,000USD2,170,000USD9,018,000USD28,930,000USD3,648,000USD
    Research Development202,016,000USD198,945,000USD165,380,000USD164,568,000USD152,919,000USD141,595,000USD120,902,000USD114,790,000USD
    Selling General Administrative165,527,000USD158,250,000USD175,072,000USD143,125,000USD134,019,000USD141,545,000USD197,282,000USD88,576,000USD
    General And Administrative Expenses165,527,000USD158,250,000USD175,072,000USD143,125,000USD134,019,000USD141,545,000USD——
    Total Operating Expenses367,827,000USD357,515,000USD341,152,000USD307,804,000USD287,092,000USD283,399,000USD290,518,000USD217,316,000USD
    Operating Income-365,993,000USD415,240,000USD-339,153,000USD-306,233,000USD-284,922,000USD-274,381,000USD-266,000,000USD-213,891,000USD
    Total Other Income Expense Net71,429,000USD38,857,000USD48,784,000USD147,189,000USD15,660,000USD39,868,000USD74,547,000USD-27,515,000USD
    Interest Income36,922,000USD—43,266,000USD45,341,000USD——83,458,000USD14,299,000USD
    Income Before Tax-294,564,000USD454,097,000USD-290,369,000USD-159,044,000USD-269,262,000USD-234,513,000USD-191,453,000USD-241,406,000USD
    Income Tax Expense-3,958,000USD98,353,000USD23,332,000USD6,995,000USD4,649,000USD-25,568,000USD-8,957,000USD3,236,000USD
    Net Income-290,606,000USD355,744,000USD-313,701,000USD-166,039,000USD-273,911,000USD118,075,000USD-151,115,000USD-304,327,000USD
    Minority Interest-100,769,000USD52,750,000USD-47,810,000USD-52,520,000USD-50,556,000USD-51,306,000USD31,381,000USD26,791,000USD
    Net Income Applicable To Common Shares-189,837,000USD226,506,000USD-265,891,000USD-113,519,000USD-223,355,000USD169,381,000USD—-304,327,000USD
    Discontinued Operations—0USD0USD0USD0USD327,020,000USD——
    Cost Of Revenue——————4,412,000USD223,000USD
    Gross Profit——————24,518,000USD3,425,000USD
    Unclassified Operating Expenses——————-27,666,000USD13,950,000USD
    Interest Expense——————7,175,000USD9,247,000USD
    Net Interest Income——————76,283,000USD5,052,000USD
    Tax Provision——————-8,957,000USD3,757,000USD
    Net Income From Continuing Ops——————-182,496,000USD-331,118,000USD
    Ebit——————-184,278,000USD-199,941,000USD
    Ebitda——————-179,053,000USD-194,354,000USD
    Depreciation And Amortization——————5,225,000USD5,587,000USD
    Reconciled Depreciation——————5,225,000USD5,587,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252026-03-31 · USDFY 20242025-03-31 · USDFY 20232023-03-31 · USDFY 20222022-03-31 · USDFY 20212021-03-31 · USDFY 20202020-03-31 · USDFY 20192019-03-31 · USD
    Total Revenue8,260,000USD29,053,000USD31,530,000USD55,286,000USD23,795,000USD67,689,000USD2,324,000USD
    Research Development681,812,000USD550,413,000USD454,062,000USD483,035,000USD236,626,000USD263,217,000USD512,994,000USD
    Selling General Administrative610,466,000USD591,410,000USD383,448,000USD775,033,000USD259,878,000USD335,766,000USD237,214,000USD
    General And Administrative Expenses610,466,000USD591,410,000USD—————
    Total Operating Expenses1,293,563,000USD1,142,734,000USD837,510,000USD1,258,068,000USD1,092,636,000USD598,983,000USD750,208,000USD
    Operating Income-515,068,000USD-1,003,294,000USD-809,014,000USD-1,211,748,000USD-1,070,898,000USD-532,425,000USD-748,490,000USD
    Total Other Income Expense Net250,490,000USD321,704,000USD-75,976,000USD288,001,000USD172,351,000USD-28,561,000USD-58,692,000USD
    Interest Income178,109,000USD—32,184,000USD369,000USD1,418,000USD——
    Income Before Tax-264,578,000USD-681,590,000USD-884,990,000USD-923,747,000USD-898,547,000USD-560,986,000USD-807,182,000USD
    Income Tax Expense133,329,000USD48,174,000USD4,082,000USD369,000USD1,686,000USD7,124,000USD2,624,000USD
    Discontinued Operations0USD373,030,000USD114,561,000USD114,561,000USD114,561,000USD1,578,426,000USD-428,981,000USD
    Net Income-397,907,000USD-356,734,000USD-1,009,030,000USD-845,262,000USD-809,234,000USD1,200,509,000USD-1,041,969,000USD
    Minority Interest-98,136,000USD-184,753,000USD-106,433,000USD-78,854,000USD264,217,000USD76,533,000USD220,346,000USD
    Net Income Applicable To Common Shares-376,259,000USD-171,981,000USD-1,009,030,000USD-845,262,000USD-809,234,000USD1,122,732,000USD-1,041,969,000USD
    Cost Of Revenue——3,034,000USD8,966,000USD2,057,000USD1,131,000USD606,000USD
    Gross Profit——28,496,000USD46,320,000USD21,738,000USD66,558,000USD1,718,000USD
    Interest Expense——27,968,000USD7,041,000USD2,809,000USD7,683,000USD7,536,000USD
    Net Interest Income——4,216,000USD-6,672,000USD-1,391,000USD——
    Tax Provision——5,190,000USD369,000USD1,686,000USD——
    Net Income From Continuing Ops——-1,230,024,000USD-924,116,000USD-900,233,000USD——
    Ebit——-809,014,000USD-916,706,000USD-895,738,000USD-532,425,000USD-610,364,000USD
    Ebitda——-790,157,000USD-910,774,000USD-895,738,000USD-553,303,000USD138,126,000USD
    Depreciation And Amortization——18,857,000USD5,932,000USD175,160,000USD-20,878,000USD748,490,000USD
    Reconciled Depreciation——18,857,000USD5,932,000USD———
    Non Operating Income Net Other——56,453,000USD-90,726,000USD———
    Unclassified Operating Expenses————596,132,000USD——
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-06-30 · USDQ4 20252026-03-31 · USDQ3 20252025-12-31 · USDQ2 20252025-09-30 · USDQ1 20252025-06-30 · USDQ4 20242025-03-31 · USDQ3 20242024-12-31 · USDQ2 20242023-09-30 · USD
    Total Assets5,306,493,000USD5,708,687,000USD5,225,368,000USD5,062,598,000USD5,032,602,000USD5,436,940,000USD5,792,345,000USD2,065,543,000USD
    Cash And Equivalents1,248,456,000USD1,419,232,000USD1,478,270,000USD1,237,010,000USD1,238,459,000USD2,715,411,000USD1,990,683,000USD—
    Cash And Short Term Investments3,800,000,000USD4,300,000,000USD4,500,000,000USD4,400,000,000USD4,500,000,000USD4,900,000,000USD5,100,000,000USD1,413,705,000USD
    Short Term Investments2,593,626,000USD2,872,601,000USD3,051,708,000USD3,148,825,000USD3,264,692,000USD2,171,480,000USD3,155,825,000USD5,474,000USD
    Total Current Assets4,742,080,000USD5,167,384,000USD4,659,890,000USD4,511,646,000USD4,615,751,000USD5,000,064,000USD5,363,968,000USD1,551,627,000USD
    Other Current Assets128,371,000USD105,316,000USD129,912,000USD125,811,000USD112,600,000USD113,173,000USD217,460,000USD78,393,000USD
    Other Non Current Assets29,585,000USD40,916,000USD34,563,000USD27,834,000USD31,094,000USD32,860,000USD33,879,000USD—
    Total Liabilities384,624,000USD416,275,000USD251,144,000USD257,140,000USD216,696,000USD249,742,000USD256,375,000USD—
    Total Current Liabilities283,603,000USD281,244,000USD151,964,000USD133,857,000USD113,866,000USD149,411,000USD141,484,000USD265,546,000USD
    Other Current Liabilities3,213,000USD583,000USD10,243,000USD1,476,000USD4,186,000USD1,584,000USD3,613,000USD—
    Other Non Current Liabilities6,253,000USD70,000USD677,000USD170,000USD228,000USD22,000USD307,000USD—
    Total Stockholder Equity4,231,273,000USD4,527,370,000USD4,269,255,000USD4,362,331,000USD4,345,634,000USD4,687,605,000USD5,189,472,000USD948,534,000USD
    Total Equity Including Noncontrolling Interest4,921,869,000USD5,292,412,000USD4,974,224,000USD4,805,458,000USD4,815,906,000USD5,187,198,000USD5,535,970,000USD—
    Property Plant Equipment Net90,206,000USD92,402,000USD97,008,000USD110,803,000USD101,943,000USD101,077,000USD104,458,000USD73,106,000USD
    Accounts Payable25,084,000USD18,002,000USD13,294,000USD15,064,000USD11,550,000USD23,691,000USD23,712,000USD44,123,000USD
    Short Term Debt12,384,000USD11,147,000USD10,436,000USD9,002,000USD9,402,000USD9,842,000USD9,835,000USD59,901,000USD
    Common Stock0USD0USD0USD0USD0USD0USD0USD—
    Retained Earnings-900,354,000USD-501,814,000USD-694,998,000USD-429,107,000USD-315,588,000USD116,060,000USD460,398,000USD-4,368,897,000USD
    Accumulated Other Comprehensive Income701,000USD4,358,000USD20,610,000USD19,558,000USD17,137,000USD9,438,000USD8,057,000USD-3,072,000USD
    Deferred Revenue——3,050,000USD——1,168,000USD3,037,000USD—
    Intangible Assets———————140,621,000USD
    Total Liab———————739,910,000USD
    Other Current Liab———————155,724,000USD
    Capital Stock———————0USD
    Other Liab———————36,289,000USD
    Other Assets———————49,796,000USD
    Cash———————1,413,705,000USD
    Current Deferred Revenue———————5,798,000USD
    Net Debt———————-915,729,000USD
    Short Long Term Debt———————48,998,000USD
    Short Long Term Debt Total———————497,976,000USD
    Long Term Debt———————389,445,000USD
    Long Term Investments———————250,393,000USD
    Net Receivables———————54,624,000USD
    Inventory———————4,905,000USD
    Property Plant Equipment Gross———————73,106,000USD
    Common Stock Shares Outstanding———————770,227,849shares
    Non Current Assets Total———————513,916,000USD
    Non Current Liabilities Total———————474,364,000USD
    Non Current Liabilities Other———————36,289,000USD
    Non Currrent Assets Other———————40,313,000USD
    Net Working Capital———————1,286,081,000USD
    Net Tangible Assets———————807,913,000USD
    Unclassified Non Current Assets———————-40,313,000USD
    Unclassified Current Liabilities———————-48,998,000USD
    Unclassified Non Current Liabilities———————12,341,000USD
    Unclassified Equity———————5,320,503,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252026-03-31 · USDFY 20242025-03-31 · USDFY 20232023-03-31 · USDFY 20222022-03-31 · USDFY 20212021-03-31 · USDFY 20202020-03-31 · USDFY 20192019-03-31 · USD
    Total Assets5,708,687,000USD5,436,940,000USD2,389,604,000USD2,585,129,000USD2,689,692,000USD2,477,051,000USD1,387,813,000USD
    Cash And Equivalents1,419,232,000USD2,715,411,000USD—————
    Cash And Short Term Investments4,300,000,000USD4,900,000,000USD1,681,824,000USD2,060,400,000USD2,132,745,000USD2,185,482,000USD849,551,000USD
    Short Term Investments2,872,601,000USD2,171,480,000USD5,011,000USD13,634,000USD77,701,000USD——
    Total Current Assets5,167,384,000USD5,000,064,000USD1,798,587,000USD2,146,523,000USD2,186,995,000USD2,219,245,000USD1,185,476,000USD
    Other Current Assets105,316,000USD113,173,000USD81,267,000USD79,391,000USD40,418,000USD18,484,000USD324,955,000USD
    Other Non Current Assets40,916,000USD32,860,000USD—————
    Total Liabilities416,275,000USD249,742,000USD—————
    Total Current Liabilities281,244,000USD149,411,000USD272,448,000USD184,367,000USD218,961,000USD92,118,000USD211,268,000USD
    Other Current Liabilities583,000USD1,584,000USD—————
    Other Non Current Liabilities70,000USD22,000USD—————
    Total Stockholder Equity4,527,370,000USD4,687,605,000USD1,157,766,000USD1,656,944,000USD1,897,788,000USD2,032,162,000USD937,299,000USD
    Total Equity Including Noncontrolling Interest5,292,412,000USD5,187,198,000USD—————
    Property Plant Equipment Net92,402,000USD101,077,000USD92,337,000USD86,949,000USD77,028,000USD73,932,000USD11,111,000USD
    Accounts Payable18,002,000USD23,691,000USD37,830,000USD34,583,000USD20,550,000USD10,306,000USD6,233,000USD
    Short Term Debt11,147,000USD9,842,000USD52,413,000USD11,398,000USD12,313,000USD7,839,000USD21,182,000USD
    Common Stock0USD0USD—————
    Retained Earnings-501,814,000USD116,060,000USD-3,772,754,000USD-2,763,724,000USD-1,918,462,000USD-1,109,228,000USD-2,309,737,000USD
    Accumulated Other Comprehensive Income4,358,000USD9,438,000USD-2,617,000USD-946,000USD1,445,000USD-2,349,000USD2,518,000USD
    Deferred Revenue—1,168,000USD—————
    Intangible Assets——144,881,000USD————
    Total Liab——782,017,000USD523,695,000USD527,687,000USD368,356,000USD450,514,000USD
    Other Current Liab——169,219,000USD127,531,000USD178,683,000USD69,939,000USD182,403,000USD
    Capital Stock——0USD0USD0USD——
    Other Liab——80,578,000USD66,835,000USD76,062,000USD103,194,000USD117,252,000USD
    Other Assets——49,482,000USD25,823,000USD100,000,000USD90,429,000USD22,723,000USD
    Cash——1,676,813,000USD2,060,400,000USD2,132,745,000USD2,185,482,000USD849,551,000USD
    Current Deferred Revenue——12,444,000USD10,147,000USD5,918,000USD3,621,000USD1,450,000USD
    Net Debt——-1,195,409,000USD-1,776,509,000USD-1,887,768,000USD-2,004,599,000USD-706,375,000USD
    Short Long Term Debt——40,720,000USD————
    Short Long Term Debt Total——481,404,000USD283,891,000USD244,977,000USD180,883,000USD143,176,000USD
    Long Term Debt——375,515,000USD210,025,000USD170,280,000USD——
    Long Term Investments——304,317,000USD325,834,000USD289,541,000USD——
    Net Receivables——37,644,000USD6,732,000USD13,832,000USD15,279,000USD10,970,000USD
    Inventory——2,761,000USD-16,463,000USD63,869,000USD1USD—
    Property Plant Equipment Gross——92,337,000USD86,949,000USD77,028,000USD——
    Common Stock Shares Outstanding——712,791,115shares669,753,458shares684,789,169shares684,789,169shares215,353,216shares
    Non Current Assets Total——591,017,000USD438,606,000USD502,697,000USD257,806,000USD202,337,000USD
    Non Current Liabilities Total——509,569,000USD339,328,000USD308,726,000USD276,238,000USD239,246,000USD
    Non Current Liabilities Other——134,054,000USD115,563,000USD76,062,000USD——
    Non Currrent Assets Other——49,482,000USD25,823,000USD27,197,000USD6,659,000USD21,425,000USD
    Net Working Capital——1,526,139,000USD1,962,156,000USD1,968,034,000USD——
    Net Tangible Assets——1,012,885,000USD1,679,435,000USD1,797,788,000USD2,032,162,000USD716,953,000USD
    Unclassified Non Current Assets——-49,482,000USD-25,823,000USD8,931,000USD86,786,000USD147,078,000USD
    Unclassified Current Liabilities——-40,178,000USD————
    Unclassified Non Current Liabilities——-80,578,000USD-66,835,000USD-15,978,000USD173,044,000USD121,994,000USD
    Unclassified Equity——4,933,137,000USD4,421,614,000USD3,814,805,000USD3,143,739,000USD3,244,518,000USD
    Deferred Long Term Liab———13,740,000USD2,300,000USD——
    Unclassified Current Assets————-141,570,000USD——
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-06-30 · USDQ4 20252026-03-31 · USDQ3 20252025-12-31 · USDQ2 20252025-09-30 · USDQ1 20252025-06-30 · USDQ4 20242024-03-31 · USDQ3 20242023-12-31 · USDQ2 20242023-09-30 · USD
    Depreciation600,000USD638,000USD691,000USD921,000USD1,098,000USD2,049,000USD5,385,000USD7,283,000USD
    Stock Based Compensation83,342,000USD77,169,000USD104,997,000USD81,821,000USD82,178,000USD46,724,000USD54,325,000USD49,318,000USD
    Other Non Cash Items-9,789,000USD5,516,000USD9,718,000USD-5,980,000USD-11,082,000USD-62,884,000USD-5,364,022,000USD-2,986,000USD
    Change To Liabilities-5,981,000USD62,218,000USD8,580,000USD12,520,000USD-25,000,000USD——-1,798,000USD
    Change In Working Capital-379,000USD————15,955,000USD21,195,000USD17,127,000USD
    Operating Cash Flow-270,504,000USD-163,818,000USD-196,484,000USD-185,664,000USD-204,383,000USD———
    Capital Expenditures-419,000USD-1,261,000USD4,935,000USD-7,848,000USD-4,035,000USD-349,000USD-355,000USD-275,000USD
    Net Investments281,679,000USD118,569,000USD-2,838,713,000USD128,270,000USD-1,081,681,000USD———
    Investing Cash Flow281,260,000USD173,491,000USD109,470,000USD120,422,000USD-1,085,716,000USD———
    Common Stock Issuance635,000USD———————
    Net Common Stock Issuance-206,729,000USD—0USD0USD-208,293,000USD———
    Unclassified Financing Cash Flow24,584,000USD-277,070,000USD327,813,000USD61,813,000USD20,525,000USD-220,232,000USD231,071,000USD437,056,000USD
    Financing Cash Flow-181,510,000USD-68,777,000USD328,194,000USD62,587,000USD-187,768,000USD———
    Effect Of Forex Changes On Cash315,000USD1,316,000USD430,000USD1,206,000USD815,000USD———
    Change In Cash-170,439,000USD-57,788,000USD241,610,000USD-1,449,000USD-1,477,052,000USD-177,955,000USD5,262,270,000USD-25,652,000USD
    End Cash Flow1,260,543,000USD1,430,982,000USD1,488,770,000USD1,247,160,000USD1,248,609,000USD———
    Net Debt Issuance—0USD0USD0USD0USD———
    Net Income—————-63,577,000USD5,072,665,000USD-217,851,000USD
    Total Cash From Operating Activities—————-108,457,000USD-210,452,000USD-196,427,000USD
    Free Cash Flow—————-108,806,000USD-210,807,000USD-196,702,000USD
    Investments—————6,928,000USD5,233,041,000USD-36,451,000USD
    Total Cashflows From Investing Activities—————6,928,000USD5,233,041,000USD-36,451,000USD
    Total Cash From Financing Activities—————-32,624,000USD236,639,000USD207,872,000USD
    Dividends Paid—————-6,000,000USD—-6,000,000USD
    Sale Purchase Of Stock—————222,222,000USD0USD-215,528,000USD
    Issuance Of Capital Stock—————0USD238,733,000USD—
    Begin Period Cash Flow—————6,675,975,000USD1,423,188,000USD1,439,357,000USD
    End Period Cash Flow—————6,498,020,000USD6,685,458,000USD1,413,705,000USD
    Other Cashflows From Investing Activities—————8,081,000USD5,233,396,000USD3,000USD
    Other Cashflows From Financing Activities—————-28,614,000USD5,568,000USD-86,000USD
    Unclassified Operating Cash Flow—————-46,724,000USD—-49,318,000USD
    Unclassified Investing Cash Flow—————-7,732,000USD-5,233,041,000USD—
    Net Borrowings———————-7,570,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252026-03-31 · USDFY 20242025-03-31 · USDFY 20232023-03-31 · USDFY 20222022-03-31 · USDFY 20212021-03-31 · USDFY 20202020-03-31 · USDFY 20192019-03-31 · USD
    Depreciation3,348,000USD14,071,000USD18,857,000USD5,932,000USD5,932,000USD5,932,000USD—
    Stock Based Compensation346,165,000USD289,029,000USD217,781,000USD564,956,000USD84,958,000USD122,572,000USD58,860,000USD
    Deferred Income Tax0USD0USD—————
    Other Non Cash Items-1,828,000USD-12,610,000USD33,446,000USD-340,220,000USD191,199,000USD-257,734,000USD-383,396,000USD
    Change To Liabilities58,318,000USD-19,350,000USD43,315,000USD83,967,000USD6,049,000USD6,598,000USD4,537,000USD
    Change In Working Capital76,621,000USD-18,038,000USD6,345,000USD15,719,000USD71,938,000USD15,296,000USD49,673,000USD
    Operating Cash Flow-750,349,000USD-839,451,000USD—————
    Capital Expenditures-8,209,000USD-4,599,000USD-12,690,000USD-17,436,000USD-5,806,000USD-4,916,000USD-11,396,000USD
    Net Investments-3,673,555,000USD-2,101,521,000USD—————
    Other Investing Activities2,518,000USD-79,000USD—————
    Unclassified Investing Cash Flow2,996,913,000USD339,908,000USD44,269,000USD—-320,170,000USD1,771,691,000USD23,297,000USD
    Investing Cash Flow-682,333,000USD-1,766,291,000USD—————
    Net Debt Issuance0USD-774,000USD—————
    Common Stock Issuance1,155,000USD1,028,000USD—————
    Unclassified Financing Cash Flow133,081,000USD73,184,000USD219,809,000USD-99,000,000USD441,059,000USD1,270,429,000USD413,313,000USD
    Financing Cash Flow134,236,000USD-1,219,794,000USD—————
    Effect Of Forex Changes On Cash3,767,000USD747,000USD—————
    Change In Cash-1,294,679,000USD-3,824,789,000USD-381,919,000USD-67,642,000USD-127,576,000USD1,335,931,000USD1,119,131,000USD
    End Cash Flow1,430,982,000USD2,725,661,000USD—————
    Net Common Stock Issuance—-1,293,232,000USD—————
    Net Income——-1,115,463,000USD-924,116,000USD-900,233,000USD-519,394,000USD-749,366,000USD
    Total Cash From Operating Activities——-843,393,000USD-677,729,000USD-552,138,000USD-761,832,000USD-1,024,229,000USD
    Free Cash Flow——-856,083,000USD-695,165,000USD-557,944,000USD-766,748,000USD-1,035,625,000USD
    Investments——-44,269,000USD320,170,000USD320,170,000USD-51,936,000USD-43,613,000USD
    Total Cashflows From Investing Activities——-44,269,000USD303,295,000USD-31,702,000USD1,694,790,000USD-57,608,000USD
    Net Borrowings——129,755,000USD14,810,000USD14,810,000USD51,718,000USD175,836,000USD
    Total Cash From Financing Activities——499,462,000USD306,792,000USD456,264,000USD217,163,000USD767,017,000USD
    Dividends Paid——-162,713,000USD————
    Sale Purchase Of Stock——316,000USD—-113,000USD-1,188,465,000USD-7,375,000USD
    Issuance Of Capital Stock——379,708,000USD99,000,000USD455,756,000USD——
    Begin Period Cash Flow——2,074,034,000USD2,141,676,000USD2,269,252,000USD849,551,000USD-269,580,000USD
    End Period Cash Flow——1,692,115,000USD2,074,034,000USD2,141,676,000USD2,185,482,000USD849,551,000USD
    Cash And Cash Equivalents Changes——-388,200,000USD-67,642,000USD———
    Other Cashflows From Investing Activities——-31,579,000USD600,000USD-25,896,000USD-20,049,000USD-25,896,000USD
    Other Cashflows From Financing Activities——312,295,000USD291,982,000USD508,000USD83,481,000USD185,243,000USD
    Unclassified Operating Cash Flow————-5,932,000USD-128,504,000USD—
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ3 20252025-12-31 · USDQ2 20252025-09-30 · USDQ3 20242024-12-31 · USD
    Depreciation2,710,000USD2,019,000USD12,646,000USD
    Stock Based Compensation268,996,000USD163,999,000USD205,541,000USD
    Other Non Cash Items-7,344,000USD-17,062,000USD-8,383,000USD
    Change To Liabilities-3,900,000USD-12,480,000USD-19,507,000USD
    Operating Cash Flow-586,531,000USD-390,047,000USD-666,886,000USD
    Capital Expenditures-6,948,000USD-11,883,000USD-3,788,000USD
    Net Investments-3,792,124,000USD-953,411,000USD-3,101,521,000USD
    Other Investing Activities2,518,000USD—0USD
    Unclassified Investing Cash Flow2,940,730,000USD—264,824,000USD
    Investing Cash Flow-855,824,000USD-965,294,000USD-2,840,485,000USD
    Net Debt Issuance0USD0USD-774,000USD
    Common Stock Issuance1,155,000USD774,000USD648,000USD
    Net Common Stock Issuance-208,293,000USD-208,293,000USD-997,787,000USD
    Unclassified Financing Cash Flow410,151,000USD82,338,000USD-44,728,000USD
    Financing Cash Flow203,013,000USD-125,181,000USD-1,042,641,000USD
    Effect Of Forex Changes On Cash2,451,000USD2,021,000USD1,236,000USD
    Change In Cash-1,236,891,000USD-1,478,501,000USD-4,548,776,000USD
    End Cash Flow1,488,770,000USD1,247,160,000USD2,001,674,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinal

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q4 2024Quarterly · 2024-03-31ProductLicense Milestone And Other Revenue9,622,000USDLegacy provider
    Q4 2024Quarterly · 2024-03-31ProductProduct19,308,000USDLegacy provider
    Q2 2024Quarterly · 2023-09-30ProductLicense Milestone And Other Revenue18,677,000USD0001140361-23-052721
    Q2 2024Quarterly · 2023-09-30ProductProduct18,424,000USD0001140361-23-052721
    Q1 2024Quarterly · 2023-06-30ProductLicense Milestone And Other Revenue4,965,000USD0001140361-24-036642
    Q1 2024Quarterly · 2023-06-30ProductProduct16,659,000USD0001140361-24-036642
    Q4 2023Quarterly · 2023-03-31ProductLicense Milestone And Other Revenue13,719,000USDLegacy provider
    Q4 2023Quarterly · 2023-03-31ProductProduct13,657,000USDLegacy provider
    FY 2023Yearly · 2023-03-31ProductLicense Milestone And Other Revenue33,269,000USD0001140361-24-028145
    FY 2023Yearly · 2023-03-31ProductProduct28,011,000USD0001140361-24-028145
    Q3 2023Quarterly · 2022-12-31ProductLicense Milestone And Other Revenue7,808,000USD0001140361-24-007260
    Q3 2023Quarterly · 2022-12-31ProductProduct9,244,000USD0001140361-24-007260
    Q2 2023Quarterly · 2022-09-30ProductLicense Milestone And Other Revenue7,564,000USD0001140361-23-052721
    Q2 2023Quarterly · 2022-09-30ProductProduct4,969,000USD0001140361-23-052721
    Q1 2023Quarterly · 2022-06-30ProductLicense Milestone And Other Revenue4,178,000USD0001140361-23-039406
    Q1 2023Quarterly · 2022-06-30ProductProduct141,000USD0001140361-23-039406
    FY 2022Yearly · 2022-03-31ProductLicense Milestone And Other Revenue55,286,000USD0001140361-23-031798
    FY 2022Yearly · 2022-03-31ProductProduct0USD0001140361-23-031798

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.